Cunningham Lee Anna, Wetzel Monica, Rosenberg Gary A
Departments of Neurosciences and Neurology, University of New Mexico School of Medicine, Albuquerque, New Mexico.
Glia. 2005 Jun;50(4):329-339. doi: 10.1002/glia.20169.
Matrix metalloproteinases (MMPs) are matrix-degrading enzymes involved in diverse homeostatic and pathological processes. Several MMPs are expressed within the CNS and serve important normal and pathological functions during development and adulthood. An early and major pathological effect of MMP activity after cerebral ischemia is opening of the blood-brain barrier (BBB). More recent work demonstrates emerging roles for MMPs and their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), in the regulation of neuronal cell death. In addition, MMPs and TIMPs are likely to play important roles during the repair phases of cerebral ischemia, particularly during angiogenesis and reestablishment of cerebral blood flow. This review attempts to elucidate how MMPs and TIMPs may provide detrimental or beneficial actions during the injury and repair processes after cerebral ischemia. These processes will have important implications for therapies using MMP inhibitors in stroke.
基质金属蛋白酶(MMPs)是参与多种稳态和病理过程的基质降解酶。几种MMPs在中枢神经系统中表达,并在发育和成年期发挥重要的正常和病理功能。脑缺血后MMP活性的早期主要病理作用是血脑屏障(BBB)的开放。最近的研究表明,MMPs及其天然抑制剂金属蛋白酶组织抑制剂(TIMPs)在调节神经元细胞死亡中发挥着新的作用。此外,MMPs和TIMPs可能在脑缺血的修复阶段发挥重要作用,特别是在血管生成和脑血流重建过程中。这篇综述试图阐明MMPs和TIMPs在脑缺血后的损伤和修复过程中如何产生有害或有益的作用。这些过程将对中风中使用MMP抑制剂的治疗具有重要意义。